Yokoyama, D., Hisamori, S., Deguchi, Y., Nishigori, T., Okabe, H., Kanaya, S., . . . Sakai, Y. (2021). PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma. Nature Portfolio.
Style de citation Chicago (17e éd.)Yokoyama, Daiju, et al. PTEN Is a Predictive Biomarker of Trastuzumab Resistance and Prognostic Factor in HER2-overexpressing Gastroesophageal Adenocarcinoma. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Yokoyama, Daiju, et al. PTEN Is a Predictive Biomarker of Trastuzumab Resistance and Prognostic Factor in HER2-overexpressing Gastroesophageal Adenocarcinoma. Nature Portfolio, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.